Search for European Projects

9 European Projects Found

Searched on 125080 European Projects

 FINISHED 

AMAROUT-II EUROPE (AMAROUT-II)

Start date: Oct 1, 2012, End date: Dec 31, 2017,

AMAROUT-II is a fellowship programme designed to support transnationalmobility (incoming and reintegration) of experienced researchers, togive them the opportunity to deepen and widen their skills and toprovide them with attractive working conditions. Specifically, over 4years, AMAROUT-II will offer 152 fellowships to experiencedresearchers to develop their individual research projects within theI ...
Read Project

 1

 FINISHED 

Collaborative Oncological Gene-environment Study (COGS)

Start date: May 1, 2009, End date: Jan 31, 2014,

The overarching goal of COGS is to identify individuals with an increased risk of breast, ovary and prostate cancer. Furthermore, we will evaluate the effect of inherited genetic variation on tumour characteristics and clinical outcome. We will do this through quantifying the role of genetic and environmental/lifestyle risk in the largest data set ever generated. In all, we will include over 200,0 ...
Read Project

 16

 FINISHED 

Prediction of bladder cancer disease course using risk scores that combine molecular and clinical risk factors (UROMOL)

Start date: Feb 1, 2008, End date: Jul 31, 2013,

"Bladder cancer is a recurrent and very prevalent cancer and it generates the highest cost per patient in Europe. New genomic methods have allowed identifying new markers with potential clinical application. However, due to the use of single-marker assays and poor study design, none of these markers has made it to the clinic. FGFR3 and PIK3CA mutations, expression profiles, and microsatellite alte ...
Read Project

 8

 FINISHED 

Understanding inflammation-associated tumorigenesis for the rational design of novel anti-cancer therapeutic strategies (INFLA-CARE)

Start date: Jan 1, 2009, End date: Jun 30, 2013,

Epidemiological and experimental evidence supports a link between chronic inflammation and cancer and indicates a role for inflammatory cells in the initiation, progression and metastasis of malignancy. The objective of the collaborative integrated project INFLA-CARE is to structure a European collective of scientific and technological excellence in the field of ‘Inflammation & Cancer’ which will ...
Read Project

 22

 FINISHED 

European Life-science Infrastructure for Biological Information (ELIXIR)

Start date: Nov 1, 2007, End date: Dec 31, 2012,

"The objective of the ELIXIR preparatory phase is to produce a memorandum or memoranda of understanding between organisations (government agencies, research councils, funding bodies and scientific organisations) within the member states, with the purpose of constructing a world class and globally positioned European infrastructure for the management and integration of information in the life scien ...
Read Project

 33

 FINISHED 

Novel MS-based strategies to Discover and Evaluate Cancer Biomarkers in urine: Application to Diagnosis of Bladder Cancer (DECanBio)

Start date: Mar 1, 2008, End date: Jul 31, 2012,

In clinical studies, proteomics and transcriptomics allow the comparison of samples from different patients and hold special promise for the discovery of novel biomarkers and the development of “personalized medicine” approaches. Yet, translating recent discoveries into daily medical practice takes time and despite intensified researchers’ interest and investments, the rate of introduction of nove ...
Read Project

 9

 FINISHED 

The use of Methylated DNA Immunoprecipitation MeDIP in cancer for better clinical management (CANCERDIP)

Start date: Jan 1, 2008, End date: Jun 30, 2011,

"Aberrant DNA methylation is the most common molecular lesion of the cancer cell. Neither gene mutation nor cytogenetic abnormalities are as common in human tumours as DNA methylation alterations. The stability of our genome and correct gene expression is maintained to a great extent thanks to a perfectly preestablished pattern of DNA methylation and histone modifications. In cancer this idealisti ...
Read Project

 7

 FINISHED 

Identification and characterization of novel human telomere-related biomarkers that aid cancer management by improving patient diagnosis, treatment selection, response monitoring, and drug development (TeloMarker)

Start date: Feb 1, 2008, End date: Jan 31, 2011,

Telomeres are DNA-nucleoprotein structures that protect the ends of human chromosomes through the formation of a ‘cap’ that prevents exonucleolytic degradation, inter- & intra-chromosomal fusion and subsequent chromosomal instability. Telomerase, the ribonucleoprotein enzyme that maintains linear chromosomal DNA ends by the addition of TTAGGG repeats, is completely repressed or present only at low ...
Read Project

 8

 FINISHED 

Genomic Instability in Cancer and Precancer (GENICA)

Start date: Jan 1, 2008, End date: Dec 31, 2010,

"Genomic instability is a characteristic of practically all human cancers. Recent results generated by members of this Consortium suggest that signs of genomic instability are evident from the very beginning of human cancer development, even in precancerous lesions. In these early lesions, the genomic instability affects primarily specific genomic loci, called common fragile sites. Because common ...
Read Project

 11